Cited 0 times in
Emerging resistance of anaerobic bacteria to antimicrobial agents in South Korea
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 이경원 | - |
dc.date.accessioned | 2021-09-28T08:12:02Z | - |
dc.date.available | 2021-09-28T08:12:02Z | - |
dc.date.issued | 1996-12 | - |
dc.identifier.issn | 1058-4838 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/183486 | - |
dc.description.abstract | In previous studies, Bacteroides fragilis group organisms isolated from Korean patients were more frequently resistant to various antimicrobial agents, including clindamycin, than were isolates in other countries. A recent report of increased resistance of Peptostreptococcus species prompted us to include such isolates in a study of antimicrobial susceptibility. anaerobes isolated in 1994 at a tertiary care hospital in Seoul were tested by agar dilution method. None of the B. fragilis group organisms were resistant to imipenem, cefoxitin, chloramphenicol, or metronidazole. However, 6.7% were resistant to ampicillin/sulbactam, 20.2% to cefotetan, 30.3% to piperacillin, 48.3% to cefotaxime, and 42.7% to clindamycin. Almost all of the Clostridium perfringens isolates were susceptible to all of the agents tested, except tetracycline. Peptostreptococcus isolates were susceptible to piperacillin, cefotaxime, and imipenem, while 7.4% were resistant to penicillin G, cefotetan, and metronidazole, and 25.9% were resistant to clindamycin. The isolates resistant to penicillin G, cefotetan, and metronidazole were identified as Peptostreptococcus anaerobius. In conclusion, besides the well-known high rate of resistance of B. fragilis group organisms to clindamycin, the emergence of resistance of Peptostreptococcus species isolates to beta-lactam drugs has become obvious in Korea. | - |
dc.description.statementOfResponsibility | restriction | - |
dc.language | English | - |
dc.publisher | Oxford University Press | - |
dc.relation.isPartOf | CLINICAL INFECTIOUS DISEASES | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.subject.MESH | Anti-Bacterial Agents / pharmacology | - |
dc.subject.MESH | Bacteria, Anaerobic / drug effects* | - |
dc.subject.MESH | Bacteria, Anaerobic / isolation & purification | - |
dc.subject.MESH | Bacterial Infections / drug therapy | - |
dc.subject.MESH | Bacterial Infections / epidemiology | - |
dc.subject.MESH | Bacterial Infections / microbiology | - |
dc.subject.MESH | Bacteroides / drug effects | - |
dc.subject.MESH | Bacteroides fragilis / drug effects | - |
dc.subject.MESH | Clindamycin / pharmacology | - |
dc.subject.MESH | Clostridium perfringens / drug effects | - |
dc.subject.MESH | Drug Resistance, Microbial* | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Korea / epidemiology | - |
dc.subject.MESH | Lactams | - |
dc.subject.MESH | Peptostreptococcus / drug effects | - |
dc.title | Emerging resistance of anaerobic bacteria to antimicrobial agents in South Korea | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Laboratory Medicine (진단검사의학교실) | - |
dc.contributor.googleauthor | Kyungwon Lee | - |
dc.contributor.googleauthor | Yunsop Chong | - |
dc.contributor.googleauthor | Seok Hoon Jeong | - |
dc.contributor.googleauthor | Xue-Song Xu | - |
dc.contributor.googleauthor | Dh Hun Kwon | - |
dc.identifier.doi | 10.1093/clinids/23.supplement_1.s73 | - |
dc.contributor.localId | A02649 | - |
dc.relation.journalcode | J00581 | - |
dc.identifier.eissn | 1537-6591 | - |
dc.identifier.pmid | 8953110 | - |
dc.identifier.url | https://academic.oup.com/cid/article/23/Supplement_1/S73/424660 | - |
dc.contributor.alternativeName | Lee, Kyungwon | - |
dc.contributor.affiliatedAuthor | 이경원 | - |
dc.citation.volume | 23 | - |
dc.citation.number | Suppl 1 | - |
dc.citation.startPage | S73 | - |
dc.citation.endPage | S77 | - |
dc.identifier.bibliographicCitation | CLINICAL INFECTIOUS DISEASES, Vol.23(Suppl 1) : S73-S77, 1996-12 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.